SOLY News and Press, Soliton Inc.

The acquisition of Arena Pharmaceuticals by Pfizer for $4.69 billion. The announcement to acquire Arena comes less than a month after Pfizer closed another $2.2 billion deal. Bottomline Technologies (EPAY), a potential deal in the works, signed a merger agreement with Thoma Bravo....

Allergan Aesthetics Completes Acquisition of Soliton -- Addition of Soliton complements Body Contouring Portfolio with expansion to treat appearance of cellulite -- PR Newswire IRVINE, Calif. , Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie comp...

On a gloomy day for the stock market, healthcare aesthetics specialist Soliton (NASDAQ: SOLY) was a luminous bright spot on Tuesday. The company's shares rocketed almost 12% higher, on news that its absorption into soon-to-be-parent AbbVie (NYSE: ABBV) is about to close. ...

Gainers: Galera Therapeutics (NASDAQ:GRTX) +106%. Nuverra Environmental Solutions (NYSE:NES) +33%. CPS Technologies (NASDAQ:CPSH) +24%. Terminix (NYSE:TMX) +21%. Alzamend Neuro (NASDAQ:ALZN) +17%. MIND Technology (NASDAQ:MIND) +17%. Landec Corporation (NASDAQ:LNDC) +13%. Soliton (NASDAQ:SOLY)...

Soliton Inc. (NASDAQ:SOLY) traded today at a new 52-week high of $22.60. So far today approximately 147,000 shares have been exchanged, as compared to an average 30-day volume of 103,000 shares. Based on a current price of $22.53, Soliton Inc. is currently 19.0% above its average consens...

Gainers: Galera Therapeutics (NASDAQ:GRTX) +116%, Alzamend Neuro (NASDAQ:ALZN) +18%, Soliton (NASDAQ:SOLY) +12%, Kiromic BioPharma (NASDAQ:KRBP) +6%, Biofrontera (NASDAQ:BFRI) +5%. Losers: Adagio Therapeutics (NASDAQ:ADGI) -78%, Adagio Th...

Soliton (NASDAQ:SOLY) jumped 12% after a Nasdaq delisting notice indicates the shares will be suspended this week after completing a sale to AbbVie (NYSE:ABBV). The merger is tentatively scheduled to close prior to market open on Dec. 16 and the stock will be halted following after-hours sess...

Soliton (NASDAQ:SOLY) jumped 11% after a Nasdaq delisting notice indicates the shares will be suspended this week after completing a sale to Abbvie (NYSE:ABBV). The merger is tentatively scheduled to close prior to market open on Dec. 16 and the stock will be halted following after hours sess...

Saint-Gobain acquires GCP for $32 per share, representing a premium of 21.12%. The tiny 0.72% spread on the GCP deal despite this being a cross-border deal, implies the market might be expecting a competing offer for. JACK wants to eat its TACO, paying a grande premium of over 66%...

R. R. Donnelley receives superior proposal from Chatham Asset Management. Sportsman's Warehouse Holdings and Great Outdoors Group called off their merger deal. PNM Resources faces opposition from New Mexico regulators. Jana Partners urges Zendesk to abandon the Momentive deal....